David Machado
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Dialysis and Renal Disease Management 1
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Bruno Zilberstein (1 shared paper)Fabiano Pinheiro da Silva (1 shared paper)Roberto de Cleva (1 shared paper)William Carlos Nahas (3 shared papers)Elias David‐Neto (3 shared papers)Renato A. Caires (2 shared papers)Inara Marques (2 shared papers)Flávio Jota de Paula (2 shared papers)
In The Last Decade
David Machado
10 papers receiving 897 citations
David Machado's Hit Papers
Peers
Comparison fields: 5 of 70
- Infectious Diseases 489
- Neurology 233
- Critical Care and Intensive Care Medicine 45
- Transplantation 24
- Nephrology 38
Countries citing papers authored by David Machado
This map shows the geographic impact of David Machado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Machado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Machado more than expected).
Fields of papers citing papers by David Machado
This network shows the impact of papers produced by David Machado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Machado. The network helps show where David Machado may publish in the future.
Co-authors
The 20 scholars most cited alongside David Machado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 501 |
| 2 | Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial Hit paper breakdown → | 2021 | 300 |
| 3 | 2012 | 42 | |
| 4 | 2001 | 34 | |
| 5 | 2015 | 11 | |
| 6 | 2020 | 9 | |
| 7 | 2021 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2000 | 6 | |
| 10 | 2015 | 1 |
About David Machado
David Machado is a scholar working on Nephrology, Infectious Diseases, Immunology, Hepatology and Neurology, having authored 10 papers that have together received 921 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Complement system in diseases (2 papers), Muscle and Compartmental Disorders (2 papers), Abdominal Surgery and Complications (1 paper), Dialysis and Renal Disease Management (1 paper), Pancreatitis Pathology and Treatment (1 paper), Hepatitis C virus research (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Infectious Diseases (489 citations), Neurology (233 citations), Critical Care and Intensive Care Medicine (45 citations), Transplantation (24 citations) and Nephrology (38 citations). David Machado has collaborated with scholars based in Brazil and Portugal. Frequent co-authors include Bruno Zilberstein, Fabiano Pinheiro da Silva, Roberto de Cleva, William Carlos Nahas, Elias David‐Neto, Renato A. Caires, Inara Marques, Flávio Jota de Paula, Victor Augusto Hamamoto Sato and Luis Estevan Ianhez. Their work appears in journals such as Frontiers in Medicine, JAMA, Transplant International, Clinical Kidney Journal and Peritoneal Dialysis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.